PL3240550T3 - Kombinacja glikozaminoglikanów i środka zobojętniającego kwas i ich kompozycje - Google Patents

Kombinacja glikozaminoglikanów i środka zobojętniającego kwas i ich kompozycje

Info

Publication number
PL3240550T3
PL3240550T3 PL16795133T PL16795133T PL3240550T3 PL 3240550 T3 PL3240550 T3 PL 3240550T3 PL 16795133 T PL16795133 T PL 16795133T PL 16795133 T PL16795133 T PL 16795133T PL 3240550 T3 PL3240550 T3 PL 3240550T3
Authority
PL
Poland
Prior art keywords
glycosaminoglycans
compositions
combination
antacid agent
antacid
Prior art date
Application number
PL16795133T
Other languages
English (en)
Inventor
Angelo Pizzoni
Paolo Pizzoni
Original Assignee
Apharm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITUB2015A004158A external-priority patent/ITUB20154158A1/it
Application filed by Apharm Srl filed Critical Apharm Srl
Publication of PL3240550T3 publication Critical patent/PL3240550T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL16795133T 2015-10-01 2016-09-30 Kombinacja glikozaminoglikanów i środka zobojętniającego kwas i ich kompozycje PL3240550T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITUB2015A004158A ITUB20154158A1 (it) 2015-10-01 2015-10-01 Associazione di glicosamminoglicani e magaldrato e composizioni che la contengono.
ITUA2016A002869A ITUA20162869A1 (it) 2015-10-01 2016-04-26 Associazione di glicosamminoglicani e un agente antiacido e composizioni che la contengono.
PCT/IB2016/001423 WO2017055909A1 (en) 2015-10-01 2016-09-30 Combination of glycosaminoglycans and an antacid agent and compositions thereof
EP16795133.4A EP3240550B1 (en) 2015-10-01 2016-09-30 Combination of glycosaminoglycans and an antacid agent and compositions thereof

Publications (1)

Publication Number Publication Date
PL3240550T3 true PL3240550T3 (pl) 2019-10-31

Family

ID=57288470

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16795133T PL3240550T3 (pl) 2015-10-01 2016-09-30 Kombinacja glikozaminoglikanów i środka zobojętniającego kwas i ich kompozycje

Country Status (8)

Country Link
US (1) US11116786B2 (pl)
EP (1) EP3240550B1 (pl)
KR (1) KR20180081508A (pl)
CA (1) CA2999411A1 (pl)
EA (1) EA037070B9 (pl)
MX (1) MX2018003975A (pl)
PL (1) PL3240550T3 (pl)
WO (1) WO2017055909A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201600101413A1 (it) 2016-10-10 2018-04-10 Sofar Swiss S A Composizione liquida per uso nel trattamento del reflusso gastroesofageo
IT201700124424A1 (it) * 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali
IT201700124434A1 (it) * 2017-10-31 2019-05-01 Sofar Swiss Sa Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD.
IT201800006400A1 (it) * 2018-06-18 2019-12-18 Composizione per le patologie gastriche ed esofagee
IT201900024958A1 (it) * 2019-12-20 2021-06-20 Neilos S R L Composizione per la protezione della mucosa gastro-intestinale e per la prevenzione e il trattamento di patologie ad essa associate
IT202000016531A1 (it) * 2020-07-08 2022-01-08 Italian Devices S R L Composizioni mucoadesive e filmogene
IT202000022477A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
IT202000022471A1 (it) * 2020-09-23 2022-03-23 Sofar Swiss Sa Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo
WO2022097036A1 (en) * 2020-11-03 2022-05-12 Neilos S.r.l. Composition for use in the prevention and treatment of diseases of the gastrointestinal system and of the related symptoms
IT202100021992A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee
IT202100021995A1 (it) * 2021-08-27 2023-02-27 Neilos S R L Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4676984A (en) * 1985-08-14 1987-06-30 American Home Products Corp. Rehydratable antacid composition
DE19859231A1 (de) * 1998-12-21 2000-06-29 Kurt Heinz Bauer Schäumende Antacida-Suspensionstabletten
ITMI20012200A1 (it) 2001-10-22 2003-04-22 Ibsa Inst Biochimique Sa Processo per la preparazione di condroitin solfati dal polisaccaride k4 e prodotti ottenuti
US9241953B2 (en) * 2008-05-13 2016-01-26 Apharm S.R.L. Glycosaminoglycan oral use and compositions
EP2435021B1 (en) 2009-05-25 2013-07-03 Pharcoterm S.R.L. Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
TWM399771U (en) 2010-10-29 2011-03-11 Jian Xue Qin Y-axis aligned twin spindle C-model vertical machining center with dual Z-axis function

Also Published As

Publication number Publication date
US11116786B2 (en) 2021-09-14
MX2018003975A (es) 2018-09-06
EA037070B1 (ru) 2021-02-02
EP3240550B1 (en) 2019-04-10
EA201890842A1 (ru) 2018-09-28
KR20180081508A (ko) 2018-07-16
WO2017055909A1 (en) 2017-04-06
EP3240550A1 (en) 2017-11-08
EA037070B9 (ru) 2021-03-29
US20180280426A1 (en) 2018-10-04
CA2999411A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
IL285553A (en) Use of prg4 as an anti-inflammatory agent
IL256621A (en) Carrier-binder preparations and methods for their preparation and use
ZA201707981B (en) Compositions of obeticholic acid and methods of use
PL3240550T3 (pl) Kombinacja glikozaminoglikanów i środka zobojętniającego kwas i ich kompozycje
ZA201801511B (en) Flavonoid compositions and methods of use
PL3283107T3 (pl) Kompozycje zawierające kombinację ipilimumabu i nivolumabu
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
PT3352766T (pt) Composições de hialuronano de elevada elasticidade e processos para o seu uso
IL249364A0 (en) Pharmaceutical preparations that include dgla and their use
GB201502002D0 (en) Uses and compositions
IL257167A (en) Antitussive compositions and methods
SG10202106375UA (en) Pharmaceutical compositions and use thereof
GB201502026D0 (en) Uses and compositions
GB201501991D0 (en) Uses and compositions
SG11201707793YA (en) Anticariogenic agent and anticariogenic composition
IL261794A (en) Preparations and methods for using them
GB201511886D0 (en) Uses and compositions
PT3240550T (pt) Combinação de glicosaminoglicanos e um agente antiácido e suas composições
IL247645A0 (en) Preparations of seleno-organic compounds and methods of using them
GB201522814D0 (en) Compositions and uses thereof
ZA201807210B (en) Use of sugar-alcohols in tibolone compositions
GB201621959D0 (en) Compositions and their use
GB201602665D0 (en) Compositions and their use
GB201521306D0 (en) Compositions comprising nanoparticles and methods thereof